Elke De Bruyne

14PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMicro- and nanosystemsMolecular targetsMedical virologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 22, 2026
Clinical applications of epigenetic signatures in chronic pain management and health outcome prediction.

|Jun 18, 2026
Characterizing the Fate of Anti-CS1 Nanobody Displaying Extracellular Vesicles in Multiple Myeloma.

|May 08, 2026
A Syndecan-Based Genetic Approach to Coat the Surface of Small Extracellular Vesicles With Nanobodies.

|Jul 17, 2025
Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma.

Patrick Nylund, Berta Garrido-Zabala, Stefania Iliana Tziola

|Jun 25, 2025
Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma.

Robbe Heestermans, Catharina Olsen, Shervine Ameli

|Dec 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.

Rong Fan, Hatice Satilmis, Niels Vandewalle

Pageof 3

Frequent Collaborators

7 joint publications

Eline Menu

5 joint publications

Ken Maes

3 joint publications

Kim De Veirman

2 joint publications

Jerome Moreaux